Patents by Inventor Benoit Baras

Benoit Baras has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160120972
    Abstract: The present disclosure provides immunogenic compositions for the prevention and/or treatment of disease caused by dengue virus.
    Type: Application
    Filed: January 11, 2016
    Publication date: May 5, 2016
    Inventors: Benoit BARAS, Dirk GHEYSEN, Isabelle Solange Lucie KNOTT, Jean-Paul PRIEELS, Jean-Francois TOUSSAINT
  • Patent number: 9265821
    Abstract: The present disclosure provides immunogenic compositions for the prevention and/or treatment of disease caused by dengue virus.
    Type: Grant
    Filed: February 16, 2010
    Date of Patent: February 23, 2016
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Benoit Baras, Dirk Gheysen, Isabelle Solange Lucie Knott, Jean-Paul Prieels, Jean-Francois Toussaint
  • Publication number: 20120045469
    Abstract: The present invention provides an immunogenic composition comprising: an immunogenic SARS coronavirus S (spike) polypeptide, or a fragment or variant thereof; and an adjuvant comprising an oil-in-water emulsion.
    Type: Application
    Filed: December 1, 2009
    Publication date: February 23, 2012
    Applicant: GlaxoSmithKline Biologicals S.A.
    Inventors: Benoit Baras, Benoit Callendret, Nicolas Escriou, Valerie Lorin, Philippe Marianneau, Sylvie Van Der Werf, Martine Anne Cecile Wettendorff
  • Publication number: 20110318407
    Abstract: The present disclosure provides immunogenic compositions for the prevention and/or treatment of disease caused by dengue virus.
    Type: Application
    Filed: February 16, 2010
    Publication date: December 29, 2011
    Inventors: Benoit Baras, Dirk Gheysen, Isabelle Solange Lucie Knott, Jean-Paul Prieels, Jean-Francois Toussaint
  • Publication number: 20100233250
    Abstract: The present invention provides a vaccine or immunogenic composition comprising: an immunogenic SARS coronavirus S (spike) polypeptide, or a fragment or variant thereof; and an adjuvant comprising a lipopolysaccharide, a saponin and a liposome.
    Type: Application
    Filed: June 20, 2008
    Publication date: September 16, 2010
    Inventors: Benoit Baras, Benoit Callendret, Nicolas Escriou, Valerie Lorin, Philippe Marianneau, Sylvie Van Der Werf, Martine Anne Cecile Wettendorff